Previous Article | Next Article ![]()
Infection and Immunity, February 2001, p. 1212-1214, Vol. 69, No. 2
Centre National de la Recherche Scientifique,
Institut de Pharmacologie Moléculaire et Cellulaire, 06560 Valbonne, France
Received 17 July 2000/Returned for modification 6 September
2000/Accepted 28 October 2000
Susceptibility of BALB/c mice to Leishmania major
depends on the early production of IL-4 by CD4+ T cells
which react to the parasite LACK antigen. Here, we show that
LACK-specific cells are rapidly recruited to the site of infection and
favor the early dissemination of L. major to the internal organs.
In contrast to mice from most
strains which develop a Th1 protective immune response when infected
with Leishmania major, susceptible BALB/c mice mount a
counterprotective Th2 response which is characterized by the expansion
of interleukin-4 (IL-4)-secreting CD4+ T cells
(12). In agreement with a critical role of IL-4 in promoting Th2 responses, L. major induces the rapid
production of IL-4 mRNA in the draining lymph nodes (LN) of infected
BALB/c mice (2, 9, 10), and immunological or genetic
manipulations aimed at neutralizing IL-4 prevent the development of Th2
cells and induce the development of a Th1 protective response (4, 13). The cells which rapidly secrete IL-4 in mice infected with L. major are class II-restricted CD4+ T cells
which react to the parasite LACK antigen and use the T-cell receptor
V While LACK-specific T cells play a critical role in susceptibility, it
was not known how rapidly these cells are recruited to the inflammatory
site. To answer this question, BALB/c mice were injected with 2 × 106 L. major promastigotes into the dermis of
the ears. Cells were recovered from the ears and the draining LN
20 h later and then analyzed by flow cytometry for the expression
of V
0019-9567/01/$04.00+0 DOI: 10.1128/IAI.69.2.1212-1214.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
T Cells That React to the Immunodominant
Leishmania major LACK Antigen Prevent Early Dissemination of
the Parasite in Susceptible BALB/c Mice
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References
8 and V
4 regions (5, 6, 10, 11). As a further
demonstration of the critical role of LACK-specific cells in
susceptibility to L. major, BALB/c mice that were made tolerant to LACK by the transgenic expression of LACK in the thymus or
by the deletion of V
4+ T cells exhibited an impaired Th2
response and eventually healed (5, 10). In addition,
treatment of V
4-deficient BALB/c mice with IL-4 during the first
64 h after infection led to Th2 cell development and
susceptibility to infection (3). Thus, the critical role
of the LACK-specific T cells in susceptibility to L. major
is likely to result from their unusual ability to rapidly secrete IL-4
in infected mice.
8 and V
4 (Fig. 1). While the
proportions of V
8+, V
4+, and
V
8+ V
4+ cells were similar in the
draining LN of infected mice and in those of naive animals, these cells
were more frequent at the site of infection. Thus, the frequency of
V
8+ V
4+ CD4+ T cells was 20- to 30-fold higher in the ears of infected BALB/c mice than in the
draining LN. In striking contrast, no increase in the proportion of
V
8+ V
4+ cells was found in the ears of
LACK-tolerant BALB/c-derived IE-LACK transgenic mice (Fig.
2). Thus, most of the V
8 V
4 cells
which were recovered from the ears of infected BALB/c mice most likely reacted to LACK.

View larger version (31K):
[in a new window]
FIG. 1.
V
8+ V
4+ CD4+ T
cells are rapidly recruited to the site of parasite injection in
susceptible BALB/c mice. BALB/c-derived IE-LACK transgenic mice
(5) and BALB/c mice were infected with 2 × 106 stationary-phase L. major promastigotes in
the dermis of the ear as previously described (1). At
20 h after infection, cells were recovered from the draining LN of
uninfected (dashed bars) or infected (open bars) mice and from the ears
of infected mice (solid bars). To recover cells from the ears, the ears
were collected, separated into ventral and dorsal leaflets, and
transferred, dermal site down, to culture medium into a six-well
hydrophobic bottom plate. Non adherent cells were recovered 18 h
later and filtered through a 70-µm (pore-size) nylon cell strainer.
Viable cells were further purified by passage through a Ficoll-Hypaque
gradient (d = 1.083) and stained with
fluorochrome-conjugated anti-CD4 (GK1.5), and anti-V
4 (KT4.1),
anti-V
2 (B20.1), anti-V
8 (F23.1), or anti-V
8 (B21.14)
monoclonal antibodies. Viable lymphocytes (106 cells/
sample) were analyzed on a FACScan flow cytometer using CellQuest
software. The results show the percentages of cells stained with the
indicated antibodies after gating on CD4+ T cells. The
values given are the results of a representative experiment (out of
four).

View larger version (37K):
[in a new window]
FIG. 2.
Early parasite containment in IE-LACK transgenic mice.
IE-LACK transgenic mice (solid bars) and BALB/c mice (open bars) were
infected with 2 × 106 stationary-phase L. major promastigotes into both footpads. At different times after
infection, parasite numbers were determined in the draining LN (A) and
the footpad (B) by limiting dilution assay as described elsewhere
(15). For each time point at least two animals per group
were analyzed, and a mean of at least two independent experiments is
represented. To determine the number of parasites in the site of
infection and the draining LN, serial dilutions of the tissue
homogenate were prepared. Briefly, footpads were cut above the heel and
then into several pieces and left in 4 ml of complete M199 medium
supplemented with collagenase A (1 mg/ml) at 37°C for 1 h.
Afterward, the footpads were ground vigorously using a glass tissue
homogenizer. LN were gently crushed between two glass slides in order
to get single-cell suspensions in 2 ml of complete M199 medium. Then,
serial 10-fold dilutions were prepared for both footpad and LN samples,
and 100 µl of each dilution was distributed into previously prepared
96-well plates containing 50 µl of SeaPlaque agarose (7% in complete
M199). For each dilution, at least 32 replicate wells were analyzed.
The assay was read by scoring the number of wells as positive for
parasite growth using inverted microscope, and the number of parasites
was determined applying Poisson statistics.
LACK-specific CD4+ T cells rapidly secrete IL-4 in BALB/c mice infected with L. major (2, 3, 6, 9, 10). In addition, we have recently found that these cells also secrete IL-10 (7). Since IL-4 and IL-10 prevent the killing of Leishmania parasites by macrophages (16) and since LACK-specific T cells were found in the inflammatory sites of BALB/c mice 20 h after infection, we sought to determine whether these cells could prevent the early control of parasite burden at the site of infection. To do this, we infected BALB/c and IE-LACK mice with L. major, and the numbers of parasites in the infected footpads and in the draining LN were measured by limiting dilution assays. In agreement with a critical role of the LACK-specific T cells in promoting susceptibility to L. major, the footpads and the draining LN of BALB/c mice contained more parasites than those from IE-LACK mice at all times after infection. Thus, the footpads of BALB/c mice contained four- to sixfold more parasites than those of IE-LACK transgenic mice by 20, 38, and 72 h after infection. Likewise, the LN of BALB/c mice contained more parasites than those from IE-LACK mice, even at early time points.
Early studies have shown that L. major rapidly disseminate
in susceptible BALB/c mice but not in resistant animals
(8). While parasite containment in resistant strains was
dependent on natural killer cells but not on T cells, it was not clear
whether T cells contributed to parasite dissemination in susceptible
strains. To determine if LACK-specific T cells promoted the early
dissemination of L. major in BALB/c mice, BALB/c and IE-LACK
mice were injected with 2 × 106 promastigotes into
the footpads. At different times after infection, DNA was prepared from
the spleen and the liver and then analyzed by PCR using L. major-specific primers (Table 1).
Parasite DNA was detected in the spleen and in the liver from seven
(out of nine) and five (out of nine) BALB/c mice 38 h after infection. In contrast, none of the nine IE-LACK transgenic mice which were analyzed at that time contained parasite DNA in their liver, and only
one of the nine animals contained L. major DNA in its
spleen.
|
We have shown here that the inflammatory sites of recently infected
BALB/c mice contained a higher proportion of V
8+
V
4+ T CD4+ T cells than the LN of infected
or naive animals. Since this was not the case in IE-LACK mice, most of
these T cells were likely to react to LACK. Our results are in
agreement with studies showing that LACK-specific T cells are rapidly
activated to secrete IL-4 in BALB/c mice. While the surface phenotype
of these cells could not be analyzed due to the lack of appropriate
reagents, they were shown to express CD69 as early as 16 h after
infection (10). Thus, LACK-specific T cells are rapidly
activated in the draining LN and eventually migrate to the site of
infection, possibly as the result of changes in the expression of
chemokine receptors (14).
As IL-4 is required for the differentiation of Th2 cells, LACK-specific T cells are likely to play an important role in L. major-infected mice by acting directly on naive T cells through an IL-4-dependent mechanism. We have shown here that LACK-specific T cells not only act in the draining LN but also at the site of infection by promoting the rapid replication of the parasite and its dissemination to the internal organs. Several mechanisms can account for this latter phenomenon. First, IL-4 and IL-10, which are rapidly produced by LACK-specific T cells, could prevent killing of Leishmania parasites by infected macrophages. Alternatively, these cytokines could promote increased phagocytosis or alter inflammation leading to enhanced infection.
We thank G. Milon for advice.
S.S. was supported by a fellowship from the Boehringer Ingelheim Funds. This work was supported by grants from the Association François Aupetit, the Ministère de l'Education Nationale, de la Recherche, et de l'Enseignement Supérieur (MENRT), and the DRET (contract 500098) and by EU contract QLGI-CT-1999-00050.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Centre National de la Recherche Scientifique, Institut de Pharmacologie Moléculaire et Cellulaire, 660 Route des Lucioles, 06560 Valbonne, France. Phone: 33-4-93-95-77-85. Fax: 33-4-93-95-77-08. E-mail: glaichenhaus{at}ipmc.cnrs.fr.
Editor: W. A. Petri Jr.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Belkaid, Y., H. Jouin, and G. Milon. 1996. A method to recover, enumerate and identify lymphomyeloid cells present in an inflammatory dermal site: a study in laboratory mice. J. Immunol. Methods 199:5-25[CrossRef][Medline]. |
| 2. |
Himmelrich, H.,
C. Parra-Lopez,
F. Tacchini-Cottier,
J. A. Louis, and P. Launois.
1998.
The IL-4 rapidly produced in BALB/c mice after infection with Leishmania major down-regulates IL-12 receptor beta 2-chain expression on CD4+ T cells resulting in a state of unresponsiveness to IL-12.
J. Immunol.
161:6156-6163 |
| 3. |
Himmelrich, H.,
P. Launois,
I. Maillard,
T. Biedermann,
F. Tacchini-Cottier,
R. M. Locksley,
M. Rocken, and J. A. Louis.
2000.
In BALB/c mice, IL-4 production during the initial phase of infection with Leishmania major is necessary and sufficient to instruct Th2 cell development resulting in progressive disease.
J. Immunol.
164:4819-4825 |
| 4. |
Kopf, M.,
F. Brombacher,
G. Kohler,
G. Kienzle,
K. H. Widmann,
K. Lefrang,
C. Humborg,
B. Ledermann, and W. Solbach.
1996.
IL-4-deficient BALB/c mice resist infection with Leishmania major.
J. Exp. Med.
184:1127-1136 |
| 5. |
Julia, V.,
M. Rassoulzadegan, and N. Glaichenhaus.
1996.
Resistance to Leishmania major induced by tolerance to a single antigen.
Science
274:421-423 |
| 6. |
Julia, V., and N. Glaichenhaus.
1999.
CD4+ T cells which react to the leishmania major LACK antigen rapidly secrete interleukin-4 and are detrimental to the host in resistant B10.D2 mice.
Infect. Immun.
67:3641-3644 |
| 7. |
Julia, V.,
S. McSorley,
L. Malherbe,
J.-P. Breittmayer,
F. Girard-Pipau,
A. Beck, and N. Glaichenhaus.
2000.
Priming by microbial antigens from the intestinal florza determines the ability of CD4+ T cells to rapidly secrete IL-4 in BALB/c mice infected with Leishmania major.
J. Immunol.
165:5637-5645 |
| 8. | Laskay, T., A. Diefenbach, M. Rollinghoff, and W. Solbach. 1995. Early parasite containment is decisive for resistance to Leishmania major infection. Eur. J. Immunol. 25:2220-2227[Medline]. |
| 9. | Launois, P., T. Ohteki, K. Swihart, H. R. MacDonald, and J. A. Louis. 1995. In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4+ T cells which are NK1.1. Eur. J. Immunol. 25:3298-3307[Medline]. |
| 10. |
Launois, P.,
I. Maillard,
S. Pingel,
K. G. Swihart,
I. Xenarios,
H. Acha-Orbea,
H. Diggelmann,
R. M. Locksley,
H. R. MacDonald, and J. A. Louis.
1997.
IL-4 rapidly produced by V 4+ V 8+ CD4+ T cells instructs Th2 development and susceptibility to Leishmania major in BALB/c mice.
Immunity
6:541-549[CrossRef][Medline].
|
| 11. |
Mougneau, E.,
F. Altare,
A. E. Wakil,
S. Zheng,
T. Coppola,
Z. E. Wang,
R. Waldmann,
R. M. Locksley, and N. Glaichenhaus.
1995.
Expression cloning of a protective Leishmania antigen.
Science
268:563-566 |
| 12. | Reiner, S. L., and R. M. Locksley. 1995. The regulation of immunity to Leishmania major. Annu. Rev. Immunol. 13:151-177[CrossRef][Medline]. |
| 13. |
Sadick, M. D.,
F. P. Heinzel,
B. J. Holaday,
R. T. Pu,
R. S. Dawkins, and R. M. Locksley.
1990.
Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism.
J. Exp. Med.
171:115-127 |
| 14. | Sallusto, F., B. Palermo, A. Hoy, and A. Lanzavecchia. 1999. The role of chemokine receptors in directing traffic of naive, type 1 and type 2 T cells. Curr. Top. Microbiol. Immunol. 246:123-128[Medline]. |
| 15. |
Stenger, S.,
N. Donhauser,
H. Thuring,
M. Rollinghoff, and C. Bogdan.
1996.
Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.
J. Exp. Med.
183:1501-1514 |
| 16. | Vouldoukis, I., P. A. Becherel, V. Riveros-Moreno, M. Arock, O. daSilva, P. Debre, D. Maizer, and M. D. Mossalayi. 1997. Interleukin-10 and interleukin-4 inhibit intracellular killing of Leishmania infantum and Leishmania major by human macrophages by decreasing nitric oxide generation. Eur. J. Immunol. 27:860-865[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|